Medicare Part D 2023 proposed rule could increase costs
WASHINGTON— A new report, “Medicare Part D Pharmacy Price Concessions at the Point of Sale, Potential Impacts on Stakeholder Costs” analyzed the Medicare Part D proposed rule, specifically the proposed rule’s provision to mandate the inclusion of contingent pharmacy price concessions, otherwise known as pharmacy DIR, in the “negotiated price” at the point-of-sale. Consistent with CMS’s analysis,
